US 9579407
Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals
granted A61KA61K51/0459A61K51/0463
Quick answer
US patent 9579407 (Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals) held by Takeda Pharmaceutical Company Limited expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K51/0459, A61K51/0463, A61K51/0468